| Brand name | Nonproprietary Name | Authorization date | Marketing authorisation holder |
|---|---|---|---|
| Cinqaero | reslizumab | 2016-08-15 | Teva B.V. |
EMA：Drugs approved by European Medicines Agency through centralized Procedure.
HMA：Drugs approved by EU members through Mutual Recognition Procedure.
For more information check in official website of members:
| Brand name | Nonproprietary Name | Authorization date | Marketing authorisation holder |
|---|---|---|---|
| Cinqaero | reslizumab | 2016-08-15 | Teva B.V. |